Based on findings from one study, a Moderna booster offered better protection against COVID-19 for older people who had previously received Pfizer jabs.
Key Finding from the Study
Researchers at the National Centre for Infectious Diseases (NCID) conducted a study comparing the effectiveness of different vaccine boosters. Their specific finding highlighted a benefit for a particular group receiving a Moderna booster.
The study indicated that for older individuals who completed their primary vaccination series with Pfizer jabs, getting a Moderna booster provided enhanced protection against the virus compared to other options for that group.
Specifics of the Study Group
The research focused on a defined population:
- Population: Older people
- Previous Vaccination: Received primary COVID-19 jabs using the Pfizer vaccine.
This specific group saw a notable advantage when boosted with the Moderna vaccine.
The Boosters Compared in this Study
While the study likely looked at various scenarios, the provided information specifically points to the outcome when the Moderna booster was administered to the study group detailed above.
What "Better Protection" Means
In the context of this study, "better protection" refers to an increased ability of the vaccine booster to safeguard individuals against the COVID-19 virus within the studied population.
Here is a summary of the key finding from the referenced study:
| Population | Previous Vaccine | Booster Studied | Finding (in this specific study) |
|---|---|---|---|
| Older People | Pfizer | Moderna | Better protection against virus |
It is important to note that this finding is specific to the population and previous vaccination type studied by the NCID researchers and may not apply to all individuals or all booster combinations.
